Okochi et al., 1998 - Google Patents

Presenilin 1 cleavage is a universal event in human organs

Okochi et al., 1998

Document ID
1533627957393127807
Author
Okochi M
Sahara N
Kametani F
Usami M
Arai T
Tanaka K
Ishii K
Yamamoto A
Mori H
Publication year
Publication venue
Neurobiology of aging

External Links

Snippet

A panel of antibodies raised against various regions of human presenilin 1 (PS1)—the amino-terminal domain, the domain between the transmembrane domains 1 and 2, the cleavage-site, loop domains, or carboxyl-terminal domain—was prepared to analyze PS1 in …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups

Similar Documents

Publication Publication Date Title
Thinakaran et al. Stable association of presenilin derivatives and absence of presenilin interactions with APP
Barelli et al. Characterization of new polyclonal antibodies specific for 40 and 42 amino acid-long amyloid β peptides: Their use to examine the cell biology of presenilins and the immunohistochemistry of sporadic Alzheimer’s disease and cerebral amyloid angiopathy cases
Podlisny et al. Homology of the amyloid beta protein precursor in monkey and human supports a primate model for beta amyloidosis in Alzheimer's disease.
Citron et al. Additive effects of PS1 and APP mutations on secretion of the 42-residue amyloid β-protein
Citron et al. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice
Nitsch et al. Cerebrospinal fluid levels of amyloid β‐protein in alzheimer's disease: Inverse correlation with severity of dementia and effect of apolipoprotein e genotype
Quintero-Monzon et al. Dissociation between the processivity and total activity of γ-secretase: implications for the mechanism of Alzheimer's disease-causing presenilin mutations
Hashimoto et al. CLAC: a novel Alzheimer amyloid plaque component derived from a transmembrane precursor, CLAC‐P/collagen type XXV
CA2437453C (en) Conformationally abnormal forms of tau proteins and specific antibodies thereto
FI111546B (en) In vitro method for monitoring the processing of a beta-amyloid precursor protein in cells, for the diagnosis or monitoring of a disease related to beta-amyloid or for the identification of inhibitors of beta-amyloid precursor and soluble fragment of beta-amyloid precursor protein
Saura et al. Evidence that intramolecular associations between presenilin domains are obligatory for endoproteolytic processing
Wirths et al. N-truncated Aβ 4–x peptides in sporadic Alzheimer’s disease cases and transgenic Alzheimer mouse models
US7196163B2 (en) Assays using amyloid precursor proteins with modified β-secretase cleavage sites to monitor β-secretase activity
Anderson et al. Differential brain expression of the Alzheimer's amyloid precursor protein.
Saura et al. The nonconserved hydrophilic loop domain of presenilin (PS) is not required for PS endoproteolysis or enhanced Aβ42 production mediated by familial early onset Alzheimer's disease-linked PS variants
US20210180136A1 (en) Compositions and methods for diagnosis and treatment of epilepsy
US20110065197A1 (en) Diagnostic kit for alzheimer's disease, diagnostic marker, and detection method for indicator of pathological state thereof
Levey et al. Presenilin‐1 protein expression in familial and sporadic Alzheimer's disease
Petanceska et al. Mutant presenilin 1 increases the levels of Alzheimer amyloid β‐peptide Aβ42 in late compartments of the constitutive secretory pathway
Rutten et al. No alterations of hippocampal neuronal number and synaptic bouton number in a transgenic mouse model expressing the β-cleaved C-terminal APP fragment
Razzaboni et al. A calcium-stimulated serine protease from monkey brain degrades the β-amyloid precursor protein
Kimura et al. Age-related changes in the localization of presenilin-1 in cynomolgus monkey brain
KR102063610B1 (en) Novel biomarkers for diagnosis of neurodegenerative diseases and uses thereof
US6518011B1 (en) Method for screening compounds to identify beta-amyloid production modulators
Okochi et al. Presenilin 1 cleavage is a universal event in human organs